Package Leaflet: Information for the User
Diltiazem Farmalider 200 mg prolonged-release hard capsules EFG
Diltiazem hydrochloride
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information
Diltiazem Farmalider 200 mg belongs to a group of medicines called selective calcium channel blockers with direct cardiac effects, derived from benzothiazepine.
Diltiazem Farmalider 200 mg is indicated for the preventive treatment of stable angina attacks. The prolonged-release formulation of Diltiazem Farmalider 200 mg makes it possible for the absorption of diltiazem to be carried out in a prolonged manner, allowing for single daily administration.
Do not take Diltiazem Farmalider 200 mg
Warnings and precautions
Consult your doctor or pharmacist before starting to take Diltiazem Farmalider 200 mg.
Children
Diltiazem Farmalider 200 mg is not a suitable medicine for children.
Taking Diltiazem Farmalider 200 mg with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Note that these instructions may also apply to medicines that have been taken before or may be taken after.
Certain medicines may interact with Diltiazem Farmalider 200 mg. In these cases, it may be convenient to change the dose or interrupt treatment with one of the medicines.
In particular, do not take this medicine and inform your doctor if you are taking:
It is especially important that you inform your doctor if you are taking any of the following medicines:
Medicines for heart problems, such as:
Since the effects of both can be cumulative, potentially leading to the appearance of side effects, so special caution should be exercised when combining them with diltiazem.
Since diltiazem increases the amount of these medicines circulating in the blood, your doctor will need to adjust the dose of these medicines during treatment with diltiazem.
Taking Diltiazem Farmalider 200 mg with food and drinks
The pharmacological effect of Diltiazem Farmalider 200 mg is not altered by the ingestion of food or drinks. Its administration can be carried out before or during main meals, at any time of the day, but it is recommended to always take it at the same time.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
This medicine should not be administered to pregnant women or women of childbearing age who are not using an effective contraceptive method.
This medicine should not be taken during breastfeeding, as it passes into breast milk. If the doctor considers it essential to take this medicine, the baby should be fed with an alternative method.
Driving and using machines
Based on the side effects reported with the use of Diltiazem Farmalider, such as dizziness (frequent) and malaise (frequent), the ability to drive and use machines may be impaired, although no studies have been conducted on this.
Follow exactly the administration instructions of this medicine indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again. Your doctor will indicate the duration of your treatment with Diltiazem Farmalider 200 mg. Do not stop treatment before. Remember to take your medicine.
The route of administration of Diltiazem Farmalider 200 mg is oral. The capsule should be swallowed whole, without being opened or chewed.
The dose you need will be determined by your doctor and adjusted individually for you.
The recommended dose is:
It is not recommended to substitute diltiazem specialties among themselves unless you receive the express recommendation of your doctor.
If you take more Diltiazem Farmalider 200 mg than you should
If you take more tablets than you should, inform your doctor or go immediately to the emergency department of a hospital. Take the medicine package with you. This is so that the doctor knows what you have taken. The following effects may occur: feeling of dizziness or weakness, blurred vision, chest pain, difficulty breathing, fainting, unusually fast or slow heartbeats, difficulty speaking, confusion, decreased kidney function, coma, and sudden death.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone: 91 562 04 20, indicating the medicine and the amount ingested.
If you have taken more Diltiazem Farmalider 200 mg than you should, consult your doctor or pharmacist immediately.
A too high dose of Diltiazem Farmalider 200 mg can cause a decrease in blood pressure, slowing of the heart rate, and alterations in cardiac conduction.
In case of significant overdose, the patient should be transferred to a specialized center and gastric lavage and osmotic diuresis should be performed.
Atropine, adrenaline, glucagon, or calcium gluconate may be administered as antidotes.
If you forget to take Diltiazem Farmalider 200 mg
Do not take a double dose to make up for forgotten doses.
If you forget to take a dose, take it as soon as you can and take the next one at the usual time. However, if it is already time for the next dose or it is close to it, wait and take it at this time.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects have been reported according to the frequencies detailed below:
Very common:may affect more than 1 in 10 patients
Common:may affect up to 1 in 10 patients
Uncommon:may affect up to 1 in 100 patients
Rare:may affect up to 1 in 1,000 patients
Very rare:may affect up to 1 in 10,000 patients
Frequency not known(cannot be estimated from the available data)
Blood and lymphatic system disorders:
Frequency not known:thrombocytopenia
Metabolism and nutrition disorders
Frequency not known:hyperglycemia
Nervous system disorders:
Common:headache, dizziness.
Frequency not known:movement disorders (extrapyramidal syndrome).
Psychiatric disorders:
Uncommon:nervousness, difficulty falling asleep (insomnia).
Frequency not known:mood changes including depression.
Cardiac disorders:
Common:atrioventricular block (a type of arrhythmia), palpitations.
Uncommon:slow heart rate (bradycardia).
Frequency not known:sinoatrial block, difficulty of the heart to pump blood (congestive heart failure).
General disorders and administration site conditions:
Very common:edema in the lower limbs.
Common:malaise.
Gastrointestinal disorders:
Common:constipation, difficult digestion (dyspepsia), stomach pain, nausea.
Uncommon:vomiting, diarrhea. Rare: dry mouth.
Frequency not known:inflammation of the hard palate (gingival hyperplasia).
Skin and subcutaneous tissue disorders:
Common:skin redness (erythema).
Rare:skin irritation and itching (urticaria).
Frequency not known:sensitivity to light (photosensitivity), inflammation of the throat, lips, and respiratory tract (angioedema), erythema multiforme (a serious skin disease associated with red spots, blisters), including rare cases of Stevens-Johnson syndrome (severe vesicular reactions of the skin and mucous membranes), toxic epidermal necrolysis (a scaling disease of the skin), sweating, exfoliative dermatitis (redness of the skin, itching, hair loss), and generalized acute pustular exanthema (sudden eruption accompanied by fever, with the formation of pustules or lesions on the skin surface that are characterized by being small, inflamed, full of pus, and similar to a blister). A condition in which the body's defense system attacks normal tissue, causing symptoms such as inflamed joints, fatigue, and skin rashes (called "lupus-like syndrome").
Vascular disorders:
Common:flushing.
Uncommon:low blood pressure when standing up quickly, with or without dizziness (orthostatic hypotension).
Frequency not known:vasculitis (diseases that involve inflammation of blood vessels) including leucocytoclastic vasculitis.
Hepatobiliary disorders:
Uncommon:increased levels of liver enzymes in the blood during the initial treatment period. These elevations are generally transient. Clinical hepatitis (liver disease) that disappears when treatment with diltiazem is interrupted.
Frequency not known:hepatitis (inflammatory disease that affects the liver).
Reproductive system and breast disorders:
Frequency not known:excessive breast volume in men (gynecomastia).
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines (www.notificaRAM.es). By reporting side effects, you can help provide more information on the safety of this medicine.
Do not store above 30°C.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after "EXP". The expiry date refers to the last day of the month shown.
Medicines should not be disposed of via wastewater or household waste. Place the cartons and medicines you no longer need in the SIGRE collection point at the pharmacy. Ask your pharmacist how to dispose of cartons and medicines you no longer need. This will help protect the environment.
Composition of Diltiazem Farmalider 200 mg prolonged-release capsules EFG.
Appearance of the product and contents of the pack
The Diltiazem Farmalider 200 mg capsules are opaque, white body and cap, filled with white-white pellets.
It is presented in packs of 28 prolonged-release capsules.
Marketing authorization holder
FARMALIDER, S.A. C/ Aragoneses, 15, 28108, Alcobendas (Madrid)
Toll Manufacturing Services Aragoneses, 2
Alcobendas-Madrid 28108
Farmea
10 Rue Bouché-Thomas. Zac Sud D'Orgemont
Angers F-49007 France
Lamp S Prospero S.P.A.
Via Della Pace, 25/A
41030 (San Prospero (MO)-Italy
This leaflet was approved in May 2023
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/